Submit Query Submit your query here
FAQs Frequently Asked Questions
Registration Register for COVID-19 Vaccine

Overview

The Invest India Business Immunity Platform is designed as a comprehensive resource to help businesses and investors get real-time updates on India’s active response to COVID-19 (Coronavirus). This dynamic and constantly updating platform keeps a regular track on developments in the control of the virus, provides the latest information on various central and state government initiatives, gives access to special provisions, and answers and resolves queries through emails and on WhatsApp.

With this platform, Invest India aims to bring facilitation to your doorstep!

We have also created a unified platform to bring together key Government stakeholders, industry champions and logistic providers to identify and fill the demand-supply shortages in the supplies required to combat COVID-19.

Invest India is looking for organisations that can support the supply of critical health and safety supplies and equipment, including personal protective equipment, treatment equipment, diagnostic and testing products, essential medicines, and components, as a part of the government's response to COVID-19.

Hon'ble Prime Minister, Shri Narendra Modi has launched the COVID-19 vaccination drive on 16 January 2021. This marks the beginning of the world’s largest Coronavirus vaccination program in India. 

 

Dashboard on state-wise Covid-19 vaccination of citizens in India

Steps to register for a COVID-19 vaccine:

  1. Register Yourself - Register using your Mobile no. or Aadhaar no. or any other Identity docs
  2. Choose Covid-19 Vaccine Location - Select your nearby Covid-19 Vaccine Center for vaccination
  3. Confirm Your Slot - Book your slot to Get Covid-19 Vaccine

Register Now

Our Partners

COVID-19 Dashboard

Last Updated on August 17, 2021 - 08:00 Hrs

  • 554730609

    Total Vaccination

  • 369846

    Active COVID-19 cases

  • 31448754

    Discharge/Cured COVID-19 Cases

  • 432079

    Deaths Due to COVID-19

Important Resources

Central Advisory and Notifications

Last Updated on August 17, 2021 - 08:00 Hrs
View ALL

State Advisory and Notifications

Last Updated on August 17, 2021 - 08:00 Hrs

Live Tweets

Latest News

View All

Government Updates

Relief Efforts

Innovations

Frequently Asked Questions

Last Updated on May 20, 2021 - 10:00 Hrs

  • Can I get a list of testing centres?

    India has 72 of its laboratories to test for the pandemic disease. In addition to these labs 49 more laboratories under organizations like Council of Scientific & Industrial Research (CSIR), Department of Biotechnology (DBT), and Defence Research, Development Organisation (DRDO) would be equipped to test for COVID19 by end of this week. Link

    Was this helpful?

  • Are there any testing centres near me?

    India has 72 laboratories to test for the pandemic disease. In addition to these labs, 49 more laboratories under organizations such as Council of Scientific & Industrial Research (CSIR), Department of Biotechnology (DBT), and Defence Research, Development Organisation (DRDO) would be equipped to test for COVID19 by end of this week

    Was this helpful?

  • Who all need to get tested?

    Unless you are travel history to a COVID affected country, or have been exposed to a person tested positive for COVID, there may not be a need to get tested. Currently, there has not been any case of community transmission of COVID19 in India.

    Was this helpful?

  • What is the cost of getting tested?

    There is no cost for individuals who are "required" to get tested.

    Was this helpful?

  • When can I get the test?

    All National Labs identified for COVID-19 testing shall remain open 7 days of the week.

    Was this helpful?

  • If we don’t call a {Person} for only a day, our plant would be shut/ we would incur losses, can they come?

    Government has issued advisory on Social Distancing as a measure to curb the spread of COVID-19 disease. Private sector organizations/employers should allow employees to work from home wherever feasible.

    Was this helpful?

  • A manager has to travel urgently to India in the coming week, can he/she enter India?

    All existing visas issued to nationals of any country have been suspended along with travel restrictions imposed on passengers coming from a few regions and compulsory quarantine. Kindly visit the link for more details.

    Further, Government of India has imposed a blanket ban on incoming commercial flights from all countries for a week, starting March 22, 2020

    Was this helpful?

  • How can I check more on permissions regarding international Trade?

    Please reach out to Novel Coronavirus Help Desk for EXIM Trade

    Was this helpful?

  • Whom can I contact for Micro Small and Medium Enterprise related Queries?

    Government has set up a helpdesk for all MSME related queries. The queries may be directed to the following email id - rudrapmishra@sidbi.in

    Was this helpful?

  • Karnataka

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Kerala

    State Emergency Helpline number: 0471-2552056

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Madhya Pradesh

    State Emergency Helpline number: 0755-2527177

    As per the official notification by state government, a lockdown has been announced in certain states with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Maharashtra

    State Emergency Helpline number: 020-26127394

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Manipur

    State Emergency Helpline number: 3852411668

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

     

    Was this helpful?

  • Meghalaya

    State Emergency Helpline number: 108

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Mizoram

    State Emergency Helpline number: 102

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Nagaland

    State Emergency Helpline number: 7005539653

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Delhi

    State Emergency Helpline number: 011-22307145

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Dadra and Nagar Haveli and Daman & Diu

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Jammu and Kashmir

    State Emergency Helpline number: 01912520982, 0194-2440283

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Puducherry

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details

     

    Was this helpful?

  • Lakshadweep

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Ladakh

    State Emergency Helpline number: 01982256462

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

     

    Was this helpful?

  • Chandigarh

    State Emergency Helpline number:104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

     

    Was this helpful?

  • Andaman & Nicobar Islands

    State Emergency Helpline number:03192-232102

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • West Bengal

    State Emergency Helpline number: 1800313444222, 03323412600,

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Uttar Pradesh

    State Emergency Helpline number: 18001805145

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details

     

    Was this helpful?

  • Uttarakhand

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details

     

    Was this helpful?

  • Tripura

    State Emergency Helpline number: 0381-2315879

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details

     

    Was this helpful?

  • Telangana

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Tamil Nadu

    State Emergency Helpline number: 044-29510500

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Sikkim

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Rajasthan

    State Emergency Helpline number: 0141-2225624

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Punjab

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Odisha

    State Emergency Helpline number: 9439994859

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Andhra Pradesh

    State Emergency Helpline number:0866-2410978

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Arunachal Pradesh

    State Emergency Helpline number:9436055743

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Assam

    State Emergency Helpline number:6913347770

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Bihar

    State Emergency Helpline number:104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Chhattisgarh

    State Emergency Helpline number:9779558282

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details."

     

    Was this helpful?

  • Himachal Pradesh

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Goa

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

     

    Was this helpful?

  • Gujarat

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Haryana

    State Emergency Helpline number: 8558893911

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details

    Was this helpful?

  • Jharkhand

    State Emergency Helpline number: 104

    As per the official notification by state government, a lockdown has been announced in the state with supply of essential services/ products being exempted. Kindly visit our 'Government Advisory and Notification' Section, and apply State Specific Filter for more details.

    Was this helpful?

  • Will my DPIIT recognition still happen?

    The Startup Recognition Process shall continue as before

    Was this helpful?

  • Will there be a delay in IMB meetings?

    We are awaiting official communication from DPIIT and shall inform applicants of all relevant developments.

    Was this helpful?

  • What partnered resources can be utilised?

    State wise helpline numbers

    Was this helpful?

  • Will the results of any programs and challenges be delayed?

    We will keep on updating the respective challenge pages for updated timelines.

    Was this helpful?

  • What will be the process of IMB Tax Exemption- should we expect any delay in timelines?

    We are awaiting official communication from DPIIT and shall inform applicants of all relevant developments

    Was this helpful?

  • Will the DPIIT Helpline number and email ID be working for us to raise specific queries?

    We are awaiting official communication from DPIIT and shall inform applicants of all relevant developments.

    Was this helpful?

  • What are some relief measures for the startup affected by COVID?

    1. The Finance Minister announced a number of relief measures to ease the regulatory and compliance burden of businesses including extension of timelines for filing income tax returns for (FY 18-19) from 31st March, 2020  to  30th June, 2020 and other due dates for issue  of notice, intimation, notification, approval order, sanction order, filing of appeal, furnishing of return etc. under Income Tax Act,  Wealth Tax Act etc. where the time limit is expiring between 20th March 2020  to 29th June 2020 shall be extended to 30th June 2020. Further relaxation is provided on interest rate for delayed payments of advanced tax, self-assessment tax,  regular tax, TDS etc.  made between 20th March 2020  and  30th June 2020,  reduced interest rate  at 9%  instead of 12 %/18 % per annum ( i.e. 0.75% per month instead of 1/1.5 percent per month). No late fee/penalty shall be charged for delay relating to this period.

    2. Certain relaxations have also been provided under the Companies Act to reduce the compliance burden, including financial burden of companies/ LLPs at large sch as waiver of additional fee for late filing etc.

    3. An economic package of Rs. 1.7 lakh crore to address the present economic breakdown occurred due to spread of the highly contagious coronavirus or Covid-19 infection was announced on 26th March, 2020 covering Insurance scheme for Health Workers, Food Security and Direct Benefit Transfer.

    Was this helpful?

  • What can the Indian Startup Ecosystem do in this critical time?

    The Indian Startup Ecosystem can take a page out of the European and US-based startups' playbook and work together to fight this situation. Potential measures include knowledge sharing, leasing technical resources at no or low cost, directing funds towards developing effective tools to slow-down or stop the spread. Please visit the TechCrunch COVID-19 Webpage, Slush Webpage, GGVC Webpage, and VentureLab for learning more about global startups' response to the pandemic.

    Was this helpful?

  • What is the CoronaVirus?

    As explained by the WHO, the coronaviruses is a large family of viruses which may cause illness in animals or humans. In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The most recently discovered coronavirus causes coronavirus disease COVID-19.

    Was this helpful?

  • How should I greet a person to avoid Covid-19 spread?

    As per the WHO guidelines, the best way to greet a person in such unprecedented times is by a nod, wave or a bow. 

    Was this helpful?

  • Should I avoid shaking hands because of Covid-19?

    Yes, please avoid shaking hands as respiratory viruses can be transmitted through shaking hands and touching your eyes, nose and mouth. 

    Was this helpful?

  • Why should I wash my hands frequently?

    It is very important to regularly wash and clean your hands with soap and warm water for 20 seconds or use an alcohol based hand sanitizer which will kill viruses that may be on your hands. 

    Was this helpful?

  • How do I know if it is COVID-19 or just the common flu?

    A COVID-19 infection has the same signs and symptoms as the common cold so you can only differentiate between them through lab testing to determine the virus type. 

    Was this helpful?

  • Can the virus that causes COVID-19 be transmitted through the air?

    Studies to date suggest that the virus that causes COVID-19 is mainly transmitted through contact with respiratory droplets rather than through the air. If new data arises, we will be sure to update you on it. 

    Was this helpful?

  • I am well and asymptomatic. Should I use a mask?

    According to the WHO, for individuals without respiratory symptoms, a medical mask is not required, as no evidence is available on its usefulness to protect non-sick persons.If masks are used, people should be taught on how to wear, remove, and dispose of them and on the need of hand hygiene action after removal of mask.

    Was this helpful?

  • What is the risk of my child becoming sick with COVID-19?

    Based on the present data, children do not appear to be at higher risk for COVID-19 than adults. Although it is true that some children and infants have been sick with the virus but mostly adults are the ones contracting it to date. 
     
     

    Was this helpful?

  • Are the symptoms of COVID-19 different in children than in adults?

    No. The symptoms of the virus are similar in adults and children. However, children with confirmed COVID-19 have generally mild symptoms.

    Was this helpful?

  • Should I worry about COVID-19?

    Yes ideally you should be worried about the spread of the virus. As suggested by the UN, about 1 in every 5 people who catch it need hospital care. It is therefore quite normal for people to worry about how the COVID-19 outbreak will affect them and their loved ones.To protect ourselves, as recommended by the UN, first and foremost is to regularly and thoroughly wash hands and maintain good respiratory hygiene. Secondly, keep yourself informed and follow the advice of the local central and state health authorities including any restrictions put in place on travel, movement and gatherings.

    Was this helpful?

  • What is the community spread of Covid-19?

    It is when people who do not have any travel history and are not in contact with people who have contracted the disease yet still show symptoms of the virus and are unaware of the source.  

    Was this helpful?

  • How long is the incubation period from Covid-19?

    As per the Ministry of Health and Family Welfare, the “incubation period” refers to the  time between catching the virus and beginning to show the symptoms of it. In most cases the incubation period ranges from 1-14 days, most commonly around five days. 

    Was this helpful?

  • How do I manage my personal expenses during the lockdown period?/How can I ensure that the basic needs of my family are met during the lockdown period?

     

    • The primary challenge in such times is to manage available cash and create avenues to generate cash.
    • To manage available cash, streamline your expenses. Reduce or postpone expenses which are not essential now – one way could be to draw out a list of expenses and put them in buckets like ‘expenses that can’t be postponed’,  ‘expenses that can be postponed’, ‘expenses that can be reduced’ and  try to ration the available resources.
    • Cash is generated from existing resources and from existing small assets as well (FDs, NSCs, gold, etc.) which businesses and individuals create active economic times when there are surplus incomes. The point is once the initial period is handled and situations stabilise, your regular cash flows shall enable you to once again create such assets. Please remember all of us create assets in times of surplus only to handle emergencies and this is a unique emergency.
    • You can request some of your service providers for staggered payments or for a postponement of payments.
    • The last option could be approaching a lending institution (your existing lender or a small finance bank which specialise in lending to small businesses) for emergency cash flow – but please bear in mind that while a new loan will bring in cash, it will also bring the interest burden which demands cash outgo. Be also very clear about the loan servicing required and your ability to take care of it. Ideally, this is best resorted to – if at all - when situation becomes clearer and activities restart and are stable. You may also try through the Fintech platform www.psbloansin59minutes.com  for a loan from a number of available lending institutions of your choice.
    • One of the critical things is to control cash outgo while finding ways to generate new cash.

    What are the various relief measures provided by the Government of India to tackle the Covid-19 crisis?/What are the various flagship schemes by the Government of India to deal with the crisis?
    The Finance Minister has announced a number of relief measures to deal with the crisis: 
    Income Tax
    Last date for returns extended to 30-June-2020
    Delayed payments, interest rate reduced from 12 to 9%
    No extension but on delayed deposit of TDS, only reduced interest of 9% will be charged till 30-June-20. Reduced from 18%.
    Aadhar- Pan linking date extended to 30-Jun-2020
    Vivaad se Vishwaas Scheme has been extended to 30-Jun-20; Additional charge of 10% that would have been levied, is being removed till 30-June-20
    Due Dates for Issue of Notice, Approval order, Filing of appeal, Furnishing of Returns, Return Statement, Applications, Reports, any other document or compliance, including investment in Savings instruments or investment for Roll Over benefit of Capital Gains, Wealth Tax, Benami Property, Black Money, STT Law, CTT Law, Equalisation Levy Law, Vivaas se Vishwas law, where the time limit was expiring on 20-Mar-20 shall all be extended
     
    GST 
    Last date for March April and May returns and Composition Returns extended to 30-June 2020. (staggered as in the note)
    For companies <INR 5cr turnover: no interest or late fee will be charged
    Last date for opting composition scheme has been extended to June 30, 2020. Different staggering dates will be applicable, but all will end by June 30, 2020
    Date for opting for composition scheme extended to 30-June-2020
     
    Customs and Central Excise
    Sabka Vishwas scheme that was extended to 31-March, is extended to 30-June-2020
    No interest would be levied irrespective of amount involved
    Customs clearance would operate 24x7
     
    Companies Act
    MCA registry: moratorium issued from 1st April to 31st September 2020
    No additional fees for late filing
    Board Meetings: Relaxing by a period of 60 days till the next two quarters
    Applicability of the Companies Auditor’s Report Order 2020 will be made applicable from FY 2020-2021 instead of 2019-2020
    If independent directors have not been able to hold even one meeting, the same shall not be a violation
     
    Companies Provisions
    For Newly incorporated companies: requirement to file COB within 6 months of incorporation; additional time of 6 months extended for them
    Company director who does not comply with minimum residency requirement of 182 days u/s 149, would not be treated as a violation
    Requirement to create a deposit reserve of 20% of deposits maturing in the year; this can be complied with by 30-June-2020
     
    Department of Financial Services
    Debit card holders withdrawing cash, can do it free of charge for next 3 months
    No minimum balance needed
    Reduce bank charges for digital trade transactions for all trade finance consumers
     
    Commerce
    For all practical purposes, principle adopted by any activity undertaken in commerce, for procedural and
    eligibility related issues, timelines will be extended, however there will be no extension or modification of the schemes.
     
    In case your business requires funding you may reach out to financial institutions and commercial banks for a more detailed discussion on your funding requirements. Depending upon your project nature, location and size, you can also explore financial help offered under various flagship schemes of the Government of India such as Mudra (http://www.mudra.org.in/Offerings), MSME schemes http://msme.gov.in/mob/Scheme-New.aspx) as well as State Financial Corporations (SFCs) ( http://sidbi.in/?q=state-financial-corporations) and State Industrial Development Corporations (SIDCs) (http://sidbi.in/?q=sidcs-siics). 
    In addition to this, please note that the Government has recently launched a debt fund called SIDBI Make in India Loan for Enterprises (SMILE), to provide soft term loans and loans in the nature of quasi-equity to MSMEs to meet debt-to-equity norms and pursue growth opportunities in existing MSMEs. Further details are available at the link: https://www.sidbi.in/en/products/smile 
     

    Was this helpful?

  • What are the activities in Containment Zones?

     

    1. Perimeter control is stricter
    2. Entry and Exit points have clear establishments
    3. People can only move for medical emergencies or for maintaining supply of essential goods and services
    4. Movement of a number of people and transport is significantly reduced
    5. Movement of people in and out of the perimeter will be recorded

    Was this helpful?

  • What are the measures and precautions taken for the safety and well-being of the person?

     

    As per the MHA order guidelines:

    1. Movement of individuals for all non-essential activities will be prohibited strictly between 7pm to 7 am. However, local authorities shall issue orders under appropriate provisions of the law such as prohibitory orders under Section 144 of CrPC, for this purpose and ensure stricter compliance.
    2. In all zones, people above 65 years, person with co-morbidities, pregnant women and children below age of 19 years, shall stay at home, except for meeting essential requirements and for health purposes.
    3. In Containment Zones, Out-Patient Departments (OPDs) and Medical Clinics shall not be permitted to operate. However, these may be permitted to operate in Red, Orange, and Green Zones with social distancing norms and precuations.

    Was this helpful?

  • Is delivery of non-essential goods possible through e-commerce companies?

    No e-commerce of non-essentials will not be allowed in a Red Zone areas

    Was this helpful?

  • Will offices be operational?

     

    As per MHA guidelines, private offices can operate with up to 33% strength as per requirement, with the remaining persons working from home. All government offices shall function with senior officers of the level of Deputy Secretary and above at full strength, and the remaining staff attending up to 33% as per requirement. Most of the commercial and private establishments have been allowed in the Red Zones. These include print and electronic media, IT and IT-enabled services, data and call centres, cold storage and warehousing services, private security and facility management services, and services provided by self-employed persons, except for barbers, and manufacturing units of non-essential goods.

    Was this helpful?

  • Will house helps be allowed to comes?

    Yes, house help will be allowed in all zones except containment zones. However, society rules in the zones will apply

    Was this helpful?

  • What offices are allowed to function in Red Zones?

     

    1. Special Economic Zones (SEZs), Industrial Estates and Export Oriented Undertakings with access control.
    2. Manufacturing plants of essential goods.
    3. Manufacturing of IT hardware.
    4. Jute industry units with staggered shifts and social distancing.
    5. Manufacturing units of packaging material

    Was this helpful?

  • I want to get my testing kits approved.

    Thank you for inquiring. To get your testing kit approved, you need to get clearance from DCGI and CDSCO. Our recommendation would be for you to access the Sugam Portal - https://cdscoonline.gov.in/CDSCO/homepage

    And write directly to CDSCO regarding your approval. You may email them on - dci@nic.in – with all existing approvals (European market approval, if present) as well.

    Was this helpful?

  • I have testing kits, I want to supply

    Thank you for sharing this information. You may fill up the Supplier information form available here: https://www.investindia.gov.in/bip/covid/supplies . The supply is accessible by State governments, who will reach out to you through their procurement channels. Additionally, we recommend you apply for various state/ national tenders open for sourcing testing kits.

    Was this helpful?

  • I want to import my testing kits.

    Thank you for inquiring. To get your testing kit imported and used in India, you need to get clearance from DCGI and CDSCO. Our recommendation would be for you to access the Sugam Portal - https://cdscoonline.gov.in/CDSCO/homepage

    And write directly to CDSCO regarding your approval. You may email them on - dci@nic.in – with all existing approvals (European market approval, if present) as well.

    Additionally, you may fill up the Supplier information form available here: https://www.investindia.gov.in/bip/covid/supplies . The supply is accessible by State governments, who will reach out to you through their procurement channels.

    Was this helpful?

  • I’m unable to open my factory to ramp up production of testing kits

    Please share details of where your factory is located. Each state government has made provisions to apply for temporary passes. Request you to please seek out your state policy department’s movement pass.

    Each state also has a dedicated control room manning the movement of essentials. Please refer to the following link for your state’s details: https://www.investindia.gov.in/bip/resources/state-and-central-control-rooms

    Was this helpful?

  • My raw material is stuck and my courier cant cross domestic borders

    Please share details of where your factory is located. Each state government has made provisions to apply for temporary passes. Request you to please seek out your state policy department’s movement pass.

    Each state also has a dedicated control room manning the movement of essentials. Please refer to the following link for your state’s details: https://www.investindia.gov.in/bip/resources/state-and-central-control-rooms

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: What does this Scheme cover?

    This accident insurance scheme covers;

     

    • Loss of life due to COVID19, and

    • Accidental death on account of COVID-19 related duty

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: Who can be a volunteer under this scheme?

    Volunteers are those who are drafted by the Government Official authorized by Central/State/ UT Government for care and may have come in direct contact of the COVID-19 patient

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: Who are ‘Private persons’ under this scheme?

    Private persons are those who are engaged by both public & private health care institutions/organization through an agency and were deployed /drafted for care and may have come in direct contact of the COVID-19 patient (with the proof that the service of the agencies were engaged by the institution/organization).

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: When does insurance coverage policy begins and ends?

    The duration of the policy is for a period of 90 days, starting from March 30, 2020.

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: Is there any age-limit for health workers under this scheme?

    There’s no age limit for this scheme.

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: Is individual enrolment required?

    Individual enrolment is not required.

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: Is COVID-19 laboratory test mandatory for claiming the benefit?

    Laboratory report certifying positive medical test is required for loss of life on account of COVID-19. However, it is not required in case of Accidental loss of life on account of COVID-19 related duty.

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: Whether expenses incurred on treatment or during quarantine are covered under the scheme?

    Any type of expenses related to treatment or quarantine is not covered.

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: If a person is having another Personal accident policy or life insurance policy, what is the effect of the same on claim under this policy?

    The benefit/claim under this policy is in addition to the amount payable under any other policies.

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: Documents required to claim benefits under this scheme?

    A. In case of Loss of life due to COVID19 following documents are required:

    I. Claim form duly filled and signed by the nominee/claimant.

    II. Identity proof of Deceased (Certified copy)

    III. Identity proof of the Claimant (Certified copy)

    IV. Proof of relationship between the Deceased and the Claimant (Certified copy)

    V. Laboratory Report certifying having tested Positive for COVID-19 (in Original or Certified copy)

    VI. Death summary by the Hospital where death occurred (in case death occurred in hospital) (Certified copy).

    VII. Death Certificate (in Original)

    VIII. Certificate by the Healthcare Institution/ organization/ office that the deceased was an employee of /engaged by the institution and was deployed/drafted for care and may have come in direct contact of the COVID-19 patient. For community health care workers, the Certificate should be from Medical Officer of Primary Health Centre (PHC) that ASHA/ASHA Facilitator was drafted for work related to COVID-19.

    B. In case of Accidental loss of life on account of COVID-19 related duty following documents are required:

    I. Claim form duly filled and signed by the nominee/claimant.

    II. Identity proof of Deceased (Certified copy)

    III. Identity proof of the Claimant (Certified copy)

    IV. Proof of relationship between the Deceased and the Claimant (Certified copy)

    V. Death summary by the Hospital where death occurred (in case death occurred in hospital) Page | 3 (Certified copy).

    VI. Death Certificate (in Original)

    VII. Post-mortem Report (Certified copy)

    VIII. Cancelled Cheque (desirable) (in Original)

    IX. FIR (Certified copy)

    X. Certificate by the Healthcare Institution/ organization/ office that the deceased was an employee of /engaged by the institution and had an accidental loss of life on account of COVID-19 related duty.

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: Whom to contact in case of any claim?

    The institution/department the insured person was working for has to be informed. Insurance company also be intimated at email id nia.312000@newindia.co.in

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: What is the process of submission of claim?

     

    • The claimant needs to fill up claim form along with necessary documents as prescribed
    and submit the same to Healthcare Institution/ organization/ office where the deceased
    was an employee of /engaged by the institution.
    • The respective institution will give necessary certification and forward it to competent
       authority.
       • Competent authority for State/UT is Director General Health Services /Director
          Health Services/ Director Medical Education or any other Official specifically
          authorised by the State/UT Government for this purpose.
       • Competent authority for Central Government, Central Autonomous / PSU
          Hospitals, AIIMS, INIs and Hospitals of other Central Ministries is Director or
          Medical Superintendent or Head of the concerned institution.
    • Competent authority will forward and submit claim to the insurance company for
    approval.

    Was this helpful?

  • Pradhan Mantri Garib Kalyan Package: Whom to contact from insurance company?

     

    Divisional office CDU 312000 of The New India Assurance Co.Ltd. located at B-401, Ansal Chambers 1, Bhikaji Cama Place, New Delhi-110066. Contact persons:-

    1. Mrs.Sarika Arora, Divisional Manager, email sarika.arora@newindia.co.in or nia.312000@newindia.co.in

    2. Mr.N.Ravi Rao, Deputy Manager, email id ravin.rao@newindia.co.in or niadelbroker20@gmail.com

    3.Mr.Yogendra Singh Tanwar, Administrative Officer email id yogendra.tanwar@newindia.co.in

    Was this helpful?

  • Swachhata-MoHUA App: Who is responsible for resolving complaints posted under COVID-19 categories in Swachhata-MoHUA App?

    Urban Local Bodies (ULBs) are responsible to resolve all complaints posted on Swachhata-MoHUA App. As the complaints posted under new COVID-19 categories are critical, ULBs need to take immediate action by either directly resolving the complaints or connecting the citizen with concerned departments. ULBs need to monitor the status of complaints and to ensure the resolution of same.

    Was this helpful?

  • Swachhata-MoHUA App: Will the new Covid-19 categories be part of Swachh Survekshan/ GFC/ ODF score of ULB?

    No, the complaints and resolutions under new COVID19 categories would not be evaluated under Swachh Survekshan / GFC / ODF protocols. These categories have been added only to assist citizens during the COVID-19 outbreak, and providing ULBs with another source of information about their citizens.

    Was this helpful?

  • Swachhata-MoHUA App: Can Fumigation/Sanitation be separated into different categories?

    The complaint category shall not change. However, the complainant may specify his/her request in the “More info” field, or the ULB may contact the complainant for specific requests.

    Was this helpful?

  • Can a separate category be added for reporting unregulated disposal of COVID-19 waste?

    This can be covered under the category 'Request Waste Pickup from Quarantine Area’

    Was this helpful?

  • Can a separate category be added for reporting violation of social distancing?

    This can be covered under new category ‘Violation of Lockdown during COVID-19’.

    Was this helpful?

  • Can a separate category be added for not wearing mask in hotspot areas?

    This can be covered under new category ‘Violation of Lockdown during COVID-19’.

    Was this helpful?

  • Swachhata-MoHUA App: Who is responsible for resolving complaints posted under COVID-19 categories in Swachhata-MoHUA App?

    Urban Local Bodies (ULBs) are responsible to resolve all complaints posted on Swachhata-MoHUA App. As the complaints posted under new COVID-19 categories are critical, ULBs need to take immediate action by either directly resolving the complaints or connecting the citizen with concerned departments. ULBs need to monitor the status of complaints and to ensure the resolution of same.

    Was this helpful?

  • Swachhata-MoHUA App: Will the new Covid-19 categories be part of Swachh Survekshan/GFC/ODF score of ULB?

     

    No, the complaints and resolutions under new COVID19 categories would not be evaluated under Swachh Survekshan / GFC / ODF protocols. These categories have been added only to assist citizens during the COVID-19 outbreak, and providing ULBs with another source of information about their citizens.

    Was this helpful?

  • Swachhata-MoHUA App: What happens to existing categories under SwachhataMoHUA App with addition of new categories related to COVID-19?

     

    All new COVID-19 and old categories under SwachhataMoHUA are active. Citizens may post complaints in any of these categories which need to be resolved by concerned Urban Local Body (ULB) at the earliest.

    Was this helpful?

  • Swachhata-MoHUA App: How can a ULB monitor the complaints?

    All complaints can be monitored at the Swachh.city dashboard in the same manner as the ULBs monitor other complaints on Swachhata App, on: www.swachh.city

    Was this helpful?

  • Swachhata-MoHUA App: Can Fumigation/Sanitation be separated into different categories?

    The complaint category shall not change. However, the complainant may specify his/her request in the “More info” field, or the ULB may contact the complainant for specific requests.

    Was this helpful?

  • Swachhata-MoHUA App: Food demand may be avoided as it may lead to misuse by citizens

    This is critical during COVID-19 outbreak and ULBs need to ensure food supply to needy citizens.Request for food, shelter, medicine, transport etc may be forwarded to the concerned agency / NGO / shop / vendor in that area and the complainant / citizen may be informed. However, such issues should be followed up and monitored for final disposal.

    Was this helpful?

  • Swachhata-MoHUA App: What if violation of quarantine or lockdown etc. is being managed by police/ district administration, and not directly by ULB?

    ULB can inform the relevant authority about the specific complaint, and reply may accordingly be given on Swachhata App.

    Was this helpful?

  • Swachhata-MoHUA App: Is there any helpline for resolving technical issues related to App?

     

    All queries may be mailed to: swachhbharat@janaagraha.org

    Anushka Arora, Janaagraha: 9625514474

    Escalation of unresolved issues may be taken up with:

    Sumit Arora, Janaagraha: 9818359033;

    Prabal Bhardwaj, National PMU, SBM(U):7838606896

    Was this helpful?

  • INDIAN NATIONALS WHO WANT TO RETURN TO INDIA: Whether Indians transiting through UAE, Qatar, Oman and Kuwait be quarantined on arrival in India?

    Yes.

    With effect from 12.00 GMT on March 18,2020 (Port of Departure).

    Was this helpful?

  • INDIAN NATIONALS WHO WANT TO GO ABROAD: Whether Indians are allowed to go abroad?

    Indians are strongly advised to avoid non essential travel to Corona Virus affected countries. However as per latest notification passengers from certain countries shall not be allowed to enter India. Please refer to list of countries in Section A.1. 

    Was this helpful?

  • INDIAN NATIONALS WHO WANT TO GO ABROAD: Whether they will be quarantined upon arrival in India (quarantined for14 days)?

     

    1. All passengers coming from/transiting through UAE, Qatar, Oman and Kuwait after 12.00 GMT on March 18,2020 (Port of Departure) will be quarantined.

    2. Those who have visited China, Republic of Korea, Iran, Italy, Spain, France and Germany on or after Feb 15, 2020 will be quarantined.

    Was this helpful?

  • FOREIGNERS WHO ARE PRESENTLY IN INDIA: Whether they can extend their Indian visas before expiry?

     

    Yes, they should approach their jurisdictional FRRO/FROs through e-FRRO (https://indianfrro.gov.in/frro/)

    Was this helpful?

  • FOREIGNERS WHO ARE PRESENTLY IN INDIA: Whether they can go out of India and return back?

    Yes they can go out of India. However, they can return to India with fresh visa issued from Mission/Post only.

    Was this helpful?

  • FOREIGNERS WHO WANT TO COME TO INDIA: Who are not allowed?

    Restricted Countries All passengers coming from Austria,Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom effective 12.00 GMT on March 18,2020 (Port of Departure) and passengers coming from Philippines, Malaysia and Afghanistan effective 15.00 IST on March 17,2020 (Port of Departure).

    Was this helpful?

  • FOREIGNERS WHO WANT TO COME TO INDIA: Whether Employment and project visa holders allowed from restricted countries?

    Yes

    Was this helpful?

  • FOREIGNERS WHO WANT TO COME TO INDIA: Are Nepal, Bhutan and Maldives passport holders allowed?

    Nepal and Bhutan nationals are allowed. Maldives nationals would require visa.

    Was this helpful?

  • FOREIGNERS WHO WANT TO COME TO INDIA: Are foreign nationals with RC/RP/Stay Visa allowed to enter?

    Only those foreigners who have RC/RP/Stay Visa w.r.t. Employment/ Project Visas.

    Was this helpful?

  • FOREIGNERS WHO WANT TO COME TO INDIA: Is COVID-19 Negative Certificate mandatory ?

    Please see website of Ministry of Health & Family Welfare, Govt. of India.

    Was this helpful?

  • FOREIGNERS WHO WANT TO COME TO INDIA: Who is the competent authority to issue COVID-19 Negative Certificates in Italy and Republic of Korea?

     

    Please see website of Ministry of Health & Family Welfare, Govt. of India.

    Was this helpful?

  • FOREIGNERS WHO WANT TO COME TO INDIA: Whether foreigners transiting through restricted countries allowed to enter India?

    Flights have been barred from taking passengers from restricted countries.

    Was this helpful?

  • OCI CARD HOLDERS: Are OCI Card holders allowed?

    No.

    OCI Card holders are required to obtain fresh Indian visa from Mission/Post and allowed in India except from restricted countries. Restricted Countries All passengers coming from Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Iceland, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom effective 12.00 GMT on March 18,2020 (Port of Departure) and passengers coming from Philippines, Malaysia and Afghanistan effective 15.00 IST on March 17,2020 (Port of Departure).

    Was this helpful?

  • OCI CARD HOLDERS: Are infants/children who hold foreign passports with OCI cards but parents is Indian allowed?

     

    No. Infants/Children are required to get fresh visa from Indian Mission/Post.

    Was this helpful?

  • OCI CARD HOLDERS: Whether OCI Card holders after obtaining fresh visa coming from/visited Republic of Korea and Italy require COVID-19 Negative Certificates?

    Yes

    Was this helpful?

  • DIPLOMATS,OFFICIAL,UN/INTERNATIONAL ORGANIZATIONS AND OTHERS: Are Diplomats, Official, UN/International Organization passports holders allowed to enter India?

    Yes

    Was this helpful?

  • DIPLOMATS,OFFICIAL,UN/INTERNATIONAL ORGANIZATIONS AND OTHERS: Are Diplomats, Official, UN/International Organization passports holders required to carry COVID-19 Negative Certificates if they arrive from Italy or Republic of Korea?

    Yes

    Was this helpful?

  • DIPLOMATS,OFFICIAL,UN/INTERNATIONAL ORGANIZATIONS AND OTHERS: Which are the International Organizations allowed?

     

    UN Bodies and other recognized International organizations.

    Was this helpful?

  • DIPLOMATS,OFFICIAL,UN/INTERNATIONAL ORGANIZATIONS AND OTHERS: Foreign crew allowed on GD if they have visited China, Republic of Korea, Iran, Italy, Spain, France and Germany on or after Feb 15, 2020 in their personal capacity?

    No

    Was this helpful?

  • DIPLOMATS,OFFICIAL,UN/INTERNATIONAL ORGANIZATIONS AND OTHERS: Foreign crew allowed on GD if they are coming from the restricted countries ?

    Yes

    Was this helpful?

  • Whether spending of CSR funds for COVID19 related activities shall qualify as CSR expenditure?

     

    Ministry vide general circular No. 10/2020 dated 23rd March, 2020 has clarified that spending CSR funds for COVID-19 related activities shall qualify as CSR expenditure. It is further clarified that funds may be spent for various activities related to COVID-19 under items nos. (i) and (xii) of Schedule VII relating to promotion of health care including preventive health care and sanitation, and disaster management. Further, as per general circular No. 21/2014 dated 18.06.2014, items in Schedule VII are broad based and may be interpreted liberally for this purpose.

    Was this helpful?

  • Whether payment of salary/wages to employees and workers, including contract labour, during the lockdown period can be adjusted against the CSR expenditure of the companies?

    Payment of salary/ wages in normal circumstances is a contractual and statutory obligation of the company. Similarly, payment of salary/ wages to employees and workers even during the lockdown period is a moral obligation of the employers, as they have no alternative source of employment or livelihood during this period. Thus, payment of salary/ wages to employees and workers during the lockdown period (including imposition of other social distancing requirements) shall not qualify as admissible CSR expenditure.

    Was this helpful?

  • Whether payment of wages made to casual /daily wage workers during the lockdown period can be adjusted against the CSR expenditure of the companies?

     

    Payment of wages to temporary or casual or daily wage workers during the lockdown period is part of the moral/ humanitarian/ contractual obligations of the company and is applicable to all companies irrespective of whether they have any legal obligation for CSR contribution under section 135 of the Companies Act 2013. Hence, payment of wages to temporary or casual or daily wage workers during the lockdown period shall not count towards CSR expenditure.

    Was this helpful?

  • Whether payment of exgratia to temporary /casual /daily wage workers shall qualify as CSR expenditure?

    If any ex-gratia payment is made to temporary / casual workers/ daily wage workers over and above the disbursement of wages, specifically for the purpose of fighting COVID 19, the same shall be admissible towards CSR expenditure as a onetime exception provided there is an explicit declaration to that effect by the Board of the company, which is duly certified by the statutory auditor.

    Was this helpful?

  • How much money can I get from my EPF account under this new provision to fight
    COVID-19 and do I have to refund it?

    You can get non-refundable withdrawal to the extent of the basic wages and dearness allowances for three months or up to 75% of the amount standing to your credit in the EPF account, whichever is less. The amount standing to credit in EPF includes employee’s share, employer’s share and interest thereupon.

    Since withdrawal is non-refundable, there is no requirement to refund the amount.

    Was this helpful?

  • Please illustrate the calculation of benefits

     

    If the balance in member’s EPF account as on date is Rs.50,000/- and monthly basic wage and dearness allowance is Rs.15,000/- 75% of balance of Rs.50000/- is Rs.37,500/- & amount of three months wage is Rs.45000/-. So member is eligible to get Rs.37,500/- the least of two amounts.

    Was this helpful?

  • How can I claim this amount? Do I need to submit claim form to EPFO Office?

    Like claim for all other types of advances, the claim for this advance also can be filed Online if your UAN is validated with Aadhaar and KYC of Bank account and Mobile number is seeded in UAN.

    Was this helpful?

  • Where and how can I file Online Claim?

    On the home page of website- www.epfindia.gov.in, under the TAB “COVID-19” on top right hand corner, instructions for filing online advance claim is hosted. The process is also noted below:

    a. Login to Member Interface of Unified Portal (https://unifiedportalmem.epfindia.gov.in/memberinterface)

    b. Go to Online Services>>Claim (Form-31,19,10C & 10D)

    c. Enter last 4 digits of your Bank Account and verify

    d. Click on “Proceed for Online Claim”

    e. Select PF Advance (Form 31) from the drop down

    f. Select purpose as “Outbreak of pandemic (COVID-19)” from the drop down

    g. Enter amount required and Upload scanned copy of cheque and enter your address

    h. Click on “Get Aadhaar OTP”

    i. Enter the OTP received on Aadhaar linked mobile.

    j. Claim is submitted

    Was this helpful?

  • Can I file claim through my mobile phone?

    Yes, from your mobile phone you can either i) login to (https://unifiedportal-mem.epfindia.gov.in/memberinterface) and follow steps a. to j as in Ans to Q9 to file claim OR ii) Through UMANG (Unified Mobile Application for New-age Governance) Mobile APP Home> EPFO> Employee Centric Services> Raise Claim> Login with your UAN and OTP received on your mobile number registered with UAN to file claim

    Was this helpful?

  • Who is eligible for the advance from EPF to fight COVID-19 Pandemic?

    Any member of EPF Scheme, 1952 with UAN (Universal account number) employed in any establishment or factory covered under EPF & MP Act, 1952.

    Was this helpful?

  • Under which provision of the EPF Scheme, 1952, a member is entitled for benefit?

    That a new sub-para (3) has been inserted in Paragraph 68L of the EPF Scheme, 1952 through GSR No.225(E) published in the Gazette of India (Extraordinary), Part II- Section 3sub section (1) on 28.03.2020 to provide for benefit.

    Was this helpful?

  • Can an employee working in an exempted establishment get the advance to fight
    COVID-19 pandemic from PF Trust?

    The “Terms and conditions of exemption” in Para 27AA of EPF Scheme, 1952, provides that any amendment to EPF Scheme, 1952, which is more beneficial to the employees becomes applicable to exempted establishments pending formal amendment of Trust Rules. So, employee of an exempted establishment can withdraw from his PF account maintained with the PF Trust of the establishment by making application to the PF Trust .

    Was this helpful?

  • I availed advance recently for illness. Can I avail advance to fight COVID-19 pandemic?

    Yes. This advance can be availed irrespective of advances availed earlier.

    Was this helpful?

  • KYC is not complete for my EPF account and hence I am unable to file this claim.

     

    The claim for this advance can be filed Online if your UAN is validated with Aadhaar and KYC of Bank account and Mobile number is seeded in UAN. You are requested to complete your KYC by submitting same on Member Portal. If your basic details that is name, date of birth and gender against UAN are same as that in Aadhar, you can link your Aadhar through eKYC Portal. In case of mis-match in KYC details and details in EPF account, please submit online request for demographic detail correction through your employer. The bank account details has to be digitally approved by the employer. For submitting your claim online your aadhar linked mobile will get OTP. So your aadhar should be linked with a mobile.

    Was this helpful?

  • I do not have cheque book leaf for upload while filing online claims. Can I upload front page of bank passbook?

    Front page of bank passbook pertaining to bank account seeded with your UAN can be uploaded. This page should clearly reflect your name, account number, bank, branch and IFSC code.

    Was this helpful?

  • I have applied for availing advance under ‘Natural Calamity’ purpose. Will this be treated as advance to fight COVID-19 pandemic?

     

    No. You have to apply specifically for advance to fight COVID-19 pandemic.

    Was this helpful?

  • What is Guaranteed Emergency Credit Line (GECL)?

    The GECL is a loan for which 100% guarantee would be provided by National Credit Guarantee Trustee Company (NCGTC) to Member Lending Institutions (MLIs), and which will be extended in the form of additional working capital term loan facility in case of Scheduled Commercial Banks (SCBs) and Financial Institutions (FIs), and additional term loan facility in case of Non-Banking Financial Companies (NBFCs), to eligible MSMEs/ Business Enterprises and interested Pradhan Mantri Mudra Yojana (PMMY) borrowers. Credit under GECL would be up to 20% of the borrower’s total outstanding credit up to Rs.25 crore, excluding off-balance sheet and non-fund based exposures , as on 29th February, 2020, i.e., additional credit shall be up to Rs. 5 crore.
     

    Was this helpful?

  • What is the objective of the Scheme?

    The Scheme is a specific response to the unprecedented situation COVID-19. It seeks to provide much needed relief to the MSME sector by incentivizing MLIs to provide additional credit of up to Rs. 3 lakh crore at low cost, thereby enabling MSMEs to meet their operational liabilities and restart their businesses.

    Was this helpful?

  • What is the Emergency Credit Line Guarantee Scheme?

    The Emergency Credit Line Guarantee Scheme provides 100% guarantee coverage by NCGTC to MLIs on GECL of up to Rs. 3 lakh crore to eligible MSMEs. MSMEs for the purpose of this Scheme will include MSMEs/ Business Enterprises which are constituted as Proprietorships, Partnerships, Registered Companies, Trusts and Limited Liability Partnerships (LLPs), and also interested borrowers under PMMY.

    Was this helpful?

  • Who are the MLIs under the Scheme?

    All SCBs are eligible as MLIs. NBFCs which have been in operation for at least 2 years as on 29.2.2020, and FIs will also be eligible as MLIs under the Scheme.

    Was this helpful?

  • What will be the definition of FIs for the purpose of this Scheme?

    FIs for the purpose of this Scheme will be as defined under sub-clause (i) of clause (c)
    of Section 45-I of RBI Act.

    Was this helpful?

  • To avail GECL, will it be necessary for existing loans of the borrower to be covered under existing guarantee schemes such as CGFMU or CGTMSE?

    No.

    Was this helpful?

  • Will the interest rate on GECL be capped?

    Yes, interest rates on GECL shall be capped as under:

    • For Banks and FIs, one of the RBI prescribed external benchmark linked rates +1% subject to a maximum of 9.25% per annum
    • For NBFCs, the interest rate on GECL shall not exceed 14% per annum

    The Scheme may also be operated in combination with applicable interest subvention schemes, as far as feasible.

    Was this helpful?

  • What would be the tenor of loans provided under GECL?

    The tenor of loans provided under GECL shall be four years from the date of disbursement. No pre-payment penalty shall, however, be charged by the MLIs in case of early repayment.

    Was this helpful?

  • Is there any moratorium period prescribed under the Scheme?

    Yes, a moratorium period of one year on the principal amount shall be provided for GECL funding. Interest shall, however, be payable during the moratorium period. The principal shall be repaid in 36 instalments after the moratorium period is over.

    Was this helpful?

  • Is any turnaround time prescribed for MLIs under the Scheme for sanction of GECL?

    Indicative turnaround time for loans under the Scheme shall be the same as those prescribed by Department of Financial Services for credit support in the context of COVID-19 pandemic.

    Was this helpful?

  • Will any guarantee fee be charged under the Scheme by NCGTC?

    No, NCGTC will not charge any guarantee fee under the Scheme.

    Was this helpful?

  • Will any processing fee be charged by MLIs for sanction of loans under GECL?

    Since additional credit under GECL is to be provided to existing customers, no additional processing fee shall be charged by lenders.

    Was this helpful?

  • What will be the security on credit extended under GECL? Scheme?

    The credit under GECL will rank pari passu with the existing credit facilities in terms of cash flows (including repayments) and securities, with charge on the assets financed under the Scheme to be created within a period of 3 months from the date of disbursal.

    Was this helpful?

  • Will MLIs be required to enter into any agreement with NCGTC for the purpose of this Scheme?

    Yes, MLIs will be required to submit an Undertaking to NCGTC for the purpose of this Scheme.

    Was this helpful?

  • How will the guaranteed amount be paid by NCGTC to the MLIs on invocation of the guarantee?

    75% of the guaranteed amount will be paid by NCGTC within 30 days of an eligible claim being preferred by the MLI concerned. The balance 25% will be paid on conclusion of recovery proceedings or till the decree gets time barred, whichever is earlier.

    Was this helpful?

  • Who will issue detailed operational guidelines for ECLGS, and who will have the authority to modify provisions of the Scheme/operational guidelines?

    NCGTC has issued the detailed operational guidelines for the Scheme. The Management Committee for ECLGS fund will have the authority to approve any changes to the current structure of the Scheme/ operational guidelines.

    Was this helpful?

  • I run a business enterprise and have a GST registration. However, I am not registered as an MSME nor do I have Udyog Aadhar. My Bank also does not classify me as an MSME borrower. Am I eligbile under the scheme?

    You are eligible if

    (i) you have total credit outstanding of Rs. 25 Crore or less as on 29th Feb 2020

    (ii) your turnover for 2019-20 was upto Rs. 100 Cr.

    (iii) You have a GST registration or were not required to obtain such GST registration

    Udyog Aadhar or recognition as MSME is not required under this Scheme

    Was this helpful?

  • My Bank/ NBFC has offered me a pre approved loan of 15% only though the scheme mentions 20%. Can the Bank/ NBFC do so?

    Under ECLGS, Banks/ NBFCs are to offer loans upto 20%. Actual loan extended can therefore be less than 20%. While the Bank/ NBFC is expected to be liberal in sanctioning such loans, it is also expected to evaluate credit proposals by using prudent banking judgement and use business discretion / due diligence in selecting commercially viable proposals and conduct the account(s) of the borrowers with normal banking prudence

    Was this helpful?

  • I run a retail shop. Am I eligible for coverage?

    Under ECLGS, Banks/ NBFCs are to offer loans upto 20%. Actual loan extended can therefore be less than 20%. While the Bank/ NBFC is expected to be liberal in sanctioning such loans, it is also expected to evaluate credit proposals by using prudent banking judgement and use business discretion / due diligence in selecting commercially viable proposals and conduct the account(s) of the borrowers with normal banking prudence

    Was this helpful?

  • I operate a lending business. Am I eligible?

    No please. Typically lending institutions get funds from banks/ NBFCs through onlending, refinance, asset purchase, securitization, assignment etc. There are therefore other windows available including the Partial Credit Guarantee Scheme and the Special Liquidity Facility.

    Was this helpful?

  • Are all NBFCs eligible to become MLIs with NCGTC?

    No. The NBFC must be registered with RBI, should be meeting the CRAR requirements prescribed by RBI and have been in lending business for at least two years as on 29th Feb 2020. The Managing Committee of the Scheme may prescribe additional qualification criteria from time to time.

    Was this helpful?

  • What will be the procedure for claim settlement ?

    This will be advised in due course through additional guidelines to be issued.

    Was this helpful?

  • Can new MSME borrowers get covered under the scheme?

    ECLGS scheme is only for existing borrowers on the books of the banks as on 29th Feb 2020. Any New borrowers should be covered under ongoing CGTMSE and NCGTC schemes

    Was this helpful?

  • Can co-applicant loans between entity and the promoter or director get covered under the scheme ?

    For loans having co-applicant, only those existing loans where entity is the primary co-applicant are covered under the Scheme for additional emergency funding.

    Was this helpful?

  • Are off balance sheet loans provided to MSME borrowers covered as part of the scheme?

    No, the scheme does not cover the off-balance sheet exposure. Only on balance sheet exposures outstanding as on 29th Feb, 2020 are eligible to be covered under the scheme

    Was this helpful?

  • Who can provide answers to any further queries?

    Please address your queries/suggestions to ceo@ncgtc.in

     

    Was this helpful?

  • Should we use HCQ as prophylaxis in health care workers (HCW)?

    Hydroxychloroquine (HCQ) has been advised as prophylaxis in HCW and high-risk contacts without contraindications. It can be used along with proper use of PPE and other infection control practices to protect from COVID 19. 

    Was this helpful?

  • Can Ivermectin be used for COVID patients?

    Ivermectin has been found to be a potent inhibitor of SARS CoV2 replication in vitro, but the doses required to achieve this effect in vivo far exceeds the usual dose. It is currently not recommended in the national guidelines but can be used in patients in whom HCQ is contraindicated. 

    Was this helpful?

  • Should we continue using anticoagulation post discharge?

    In our experience, there have been no delayed post-COVID thrombotic complications. Since the prothrombotic state parallels the viremic and inflammatory phase, once the patient has been discharged, the thrombotic risk also decreases. So, we don’t recommend anti-coagulation at discharge in routine COVID patients unless indicated for other reasons like DVT, prosthetic valve etc. 

    Was this helpful?

  • Sudden deaths in COVID-19

    Sudden deaths have been reported both at presentation to emergency department (ED) as well as in hospital. Reasons that have been proposed include a sudden cardiac event/ ACS, preceding silent hypoxia that went unnoticed or due to a thrombotic complication such as pulmonary thromboembolism. Patients with risk factors to develop severe COVID or with prior comorbid conditions such as CAD or chronic lung disease should be strictly monitored for their saturation. They should not be allowed to move unattended. Anticoagulant should be used in all at-risk patients who do not have any risk factors of bleeding.

    Was this helpful?

  • Methyl prednisolone vs dexamethasone

    Corticosteroids are currently indicated in moderate to severe COVID-19 patients. Recovery trial has used dexamethasone. However, both IV dexamethasone or methyl prednisolone may be used based on the availability. 

    Was this helpful?

  • What is the role of Tocilizumab?

    Tocilizumab has been approved by DCGI on compassionate ground in view of ongoing pandemic. However, it is an experimental therapy, has a limited role, and should be used only in patients with cytokine syndrome after ruling out active infections. 

    Was this helpful?

  • What is the role of Plasma therapy?

    Convalescent plasma collected from ABO matched donors with high neutralizing titers can be given to patients at risk of developing severe COVID in early stages of the disease. However, it should also be considered an experimental therapy and should be used with caution.

    Was this helpful?

  • Role of Favipiravir

    Studies have used Favipiravir mainly in mild or asymptomatic COVID, claiming to prevent progression, whereas majority of this cohort recover with just supportive care and monitoring and usually require no specific therapy. Evidence is weak for the use of Favipiravir and is currently not recommended in national guidelines.

    Was this helpful?

  • Role of antifibrotic in prevention of lung fibrosis

    There is no evidence to support the use of antifibrotic agents like pirfenidone in preventing COVID related fibrosis and hence should not be used.

    Was this helpful?

  • How to prevent depression in COVID 19 patients?

    Depression is a common finding in patients with COVID which may be because of number of reasons including staying in isolation, anxiety related to disease, social stigma, among others. Such patients need empathy and psychological counselling preferably by a trained HCW like a psychologist / psychiatrist. 

    Was this helpful?

  • Can we give Remdesivir/TCZ in a highly suspect patient who is COVID negative on all reports?

    Remdesivir/TCZ are experimental therapies, approved by DCGI in view of the ongoing pandemic. Therefore, they should not be used as empirical therapy for suspected cases. You should use these agents only in proven COVID patients, where clinically indicated.

    Was this helpful?

  • Can we try Methylene blue?

    No, there is no role of methylene blue in the management of COVID.

    Was this helpful?

  • How long can we give Remdesivir?

    Remdesivir is currently recommended for 5 days in once daily dosing.

    Was this helpful?

  • Can we use Remdesivir/TCZ prophylactically in asymptomatic patients with comorbidities?

    There is no evidence to support the use of Remdesivir/TCZ in asymptomatic patients with comorbidities

    Was this helpful?

  • Should relatives be allowed to visit COVID-19 patients admitted in the wards?

    No, relatives are not allowed to visit COVID-19 patients as they have chances to get infected and transfer it to the community.

    Was this helpful?

  • Can parents be allowed to stay with COVID-19 positive children?

    Parents can stay with the children after explaining the risk and taking consent for the same.

    Was this helpful?

  • Should we continue steroids on discharge?

    No, there is no role of steroids at the time of discharge unless indicated for any other concomitant disease.

    Was this helpful?

  • How do we maintain nutrition in a patient on ventilation?

    Patients on ventilator may require TPN or Ryle’s tube feeding depending on their underlying condition.

    Was this helpful?

  • When should we shift from NIV to invasive ventilation?

    If the patient is not able to maintain saturation, going into respiratory fatigue, or the GCS is poor to tolerate NIV, they should be considered for invasive ventilation.

    Was this helpful?

  • When should we consider a tracheostomy?

    Patients in whom prolonged ventilation is anticipated should be considered for tracheostomy.

    Was this helpful?

  • Which COVID-19 vaccines are licenced in India?

    Two vaccines that have been granted emergency use authorization by the Central Drugs Standard Control Organization (CDSCO)in India are Covishield® (AstraZeneca's vaccine manufactured by Serum Institute of India) and Covaxin® (manufactured by Bharat Biotech Limited)

    Was this helpful?

  • What is Emergency Use Authorization (EUA)/ Permission for restricted use?

    Emergency Use Authorization (EUA) is a regulatory mechanism to allow the use of vaccines and medicines to prevent and or reduce the impact of life-threatening diseases or conditions as caused by Covid19. However, before grant of the EUA, there is rigorous assessments of laboratory and clinical trial data, including data on quality, safety, production of protective antibodies and efficacy. Safety is particularly critical aspect of this scrutiny and a risk-versusbenefit evaluation is done in the context of a public health emergency. Full licensure is obtained when the manufacturer submits the complete data.EUA by Indian regulators is aligned with global guidelines.

    Was this helpful?

  • Is the EUA a new process introduced for COVID-19 Vaccine?

    Concept of EUA always existed to save the lives of people all over the world with vaccine and medicines for life threatening diseases while companies continue to obtain additional safety and effectiveness information to enable full licensure. Previously, EUAs have been granted to vaccines for outbreaks due to anthrax, Ebola, enterovirus, H7N9 influenza, and Middle East respiratory syndrome. As of January 2021, nine COVID-19 vaccines were in emergency use in numerous countries around the globe.

    Was this helpful?

  • Have the vaccines undergone the needed clinical trials before EUA?

    Both the Indian COVID 19 vaccines have completed their Phase I & II trials. Covishield® has completed its Phase III trials in UK and the bridging trial in India.

    Was this helpful?

  • What is Phase I, II and III of clinical trial for a vaccine?

    Vaccine trail phases includes:

    Phases of vaccine development/trial Purpose
    Pre-clinical Vaccine development in laboratory animals
    Phase 1 Clinical trial (small number of participants) Assess vaccine safety, immune response and determine right dosage (short duration)
    Phase 2 Clinical trial (few hundred participants) Assess safety and the ability of the vaccine to generate an immune response (short duration)
    Phase 3 Clinical trial (thousands of participants) Determine vaccine effectiveness against the disease and safety in a larger group of people (duration 1-2 years)

     

    Was this helpful?

  • Why vaccination is not provided to children who are usual target?

    COVID-19 affects all age groups; however, morbidity & mortality is several times higher in adults particularly in those above the age of 50 years. Children have either asymptomatic or mild infection. The general practice is to first evaluate any new vaccine in older population and then age reduction is done to assess the safety and effectiveness in paediatric population. The currently available vaccines have not been evaluated in children so far. There are some clinical trials now underway to test the effectiveness and safety of the COVID 19 vaccines in children.

    Was this helpful?

  • What technology has been used in development of the currently available two vaccines in India?

    Covishield® vaccine, manufactured by the Serum Institute of India, is a Viral Vector based Technology which is also used to manufacture Ebola vaccine. Covaxin® vaccine, manufactured by the Bharat Biotech, is a whole-Virion Inactivated Corona Virus Vaccine which is also used to manufacture vaccines like Influenza, Rabies and HepatitisA.

    Was this helpful?

  • What is the composition of both the vaccines?

    Composition of Covishield includes inactivated adenovirus with segments of Corona Virus, Aluminium Hydroxide Gel, L-Histidine, L-Histidine hydrochloride monohydrate, Magnesium chloride hexahydrate, Polysorbate 80, Ethanol, Sucrose, Sodium chloride, and Disodium edetate dihydrate (EDTA). Composition of Covaxin includes inactivated Corona Virus, Aluminum Hydroxide Gel, TLR 7/8 agonist, 2-Phenoxyethanol and Phosphate Buffered Saline[NKA1].

    Was this helpful?

  • Both vaccines require cold chain temperature. How is the cold chain been maintained during storage and transportation of vaccine?

    Both vaccines need to be stored and transported at +20 to +8⁰ Celsius. The cold chain for both vaccines is maintained through active and passive cold chain equipment available at approximately 29000 cold chain points across India.

    Was this helpful?

  • If I have received vaccine as a health worker, how will my family members receive the vaccine (as they are exposed as well)?

    The people at highest risk of exposure such as health care and frontline workers will receive the vaccine on priority. These personnel are also likely source of infection of their family members. Other family members will be vaccinated according to the age specific prioritization by the Government of India.

    Was this helpful?

  • Is COVISHIELD® same as the vaccine been given in UK by Astra Zeneca?

    Yes, Covishield® vaccine, manufactured by the Serum Institute of India, is based on the same patent technology as the Astra Zeneca vaccine.

    Was this helpful?

  • What is the dose schedule of both the vaccines?

    As per the permission granted by the Drug Controller General (India), for Covisheild the second dose is to be administered 4-6 weeks after the first dose and Covaxin is to be administered in two doses interval of day 0 & day 28.

    Was this helpful?

  • Do I have a choice of vaccine I will receive?

    The vaccine will be supplied to various parts of India as per availability and distribution plan, beneficiaries load and so at present the option of choice of vaccine is not available.

    Was this helpful?

  • Is it important for me to receive the same vaccine during second dose?

    As the vaccines available are not interchangeable, it is important to receive the second dose of same vaccine as the first one. The COWIN app is also going to help to ensure that everyone receives the same vaccine.

    Was this helpful?

  • How long I will remain protected?

    The duration of protection is yet to be established.

    Was this helpful?

  • Will this require any repeated vaccination or booster dose after the 2nd dose in future?

    Requirement of booster dose is yet to be determined.

    Was this helpful?

  • Will I get any certificate that I am vaccinated?

    Yes, a provisional certificate would be provided after the first dose. On completion of second dose, when you receive the message for completion of schedule it would include a link to download digital certificate of vaccination for your perusal. This certificate can be then be saved in the digi-locker.

    Was this helpful?

  • Where can I register for COVID-19 vaccination?

    You can log into the Co-WIN portal using the link www.cowin.gov.in and click on the “Register/Sign In Yourself” tab to register for COVID-19 vaccination.

    Was this helpful?

  • Is there a mobile app that needs to be installed to register for vaccination?

    There is no authorised mobile app for registering for vaccination in India. You need to log into the Co-WIN portal. You can also register for vaccination through the ArogyaSetu App.

    Was this helpful?

  • Which age groups can register for vaccination on the Co-WIN portal?

    At present all citizens above 60 years of age and those between the age of 45 and a 59 years with one of the specified comorbidities can register for vaccination. 

    Was this helpful?

  • Is online registration mandatory for Covid 19 vaccination

    No. Vaccination Centres also provide for a limited number of on-spot registration slots every day. However, it is recommended to register online and schedule vaccination in advance for a hassle-free vaccination experience

    Was this helpful?

  • How many people can be registered in the Co-WIN portal through one mobile number?

    Up to 4 people can be registered for vaccination using the same mobile number.

    Was this helpful?

  • Where should I register for the vaccination?

    Register on the Co-WIN Portal and schedule your vaccination appointment. https://www.cowin.gov.in/home

     

    Was this helpful?

  • Where can I get the vaccine from?

    Vaccines are available from Government and Private Health Facilities as notified, known as COVID Vaccination Centres (CVCs)

    Was this helpful?

  • How do I pre-register myself online for an appointment for vaccination?

    Online registration and appointment can be done through Co-WIN portal.

    You will have to give some basic information about yourself and details of your photo identification card to get yourself registered online.

    From one mobile phone number, one can register 4 people, however, each person will need their own photo identification document.

    If Aadhar card is used as identification document, consent will be obtained and recorded.

    Through the portal, you can find out the list of available CVCs and dates and time of available vaccination slots, to book an appointment as per your choice. You will need an OTP verification prior to registration and a confirmation slip/token will be generated after registration. You will also get a confirmatory sms later.

    For all Private Hospitals, prior registration and appointment will be the only method of registration.

    For Government hospitals, a proportion of slots will be available for online registration and appointment, the rest will be kept for on site registration and vaccination.

    Appointments for any date for a Vaccination Center will be closed at 12:00 pm on the day prior to the date.

    Was this helpful?

  • If I cannot pre-register myself online, how do I register on the spot and get vaccinated?

    Those who cannot get themselves registered online can contact their local Government health workers, who will help the beneficiaries to the Government CVC for on the spot registration, appointment, verification and vaccination on the same day. Please ask your nearest Governmen health care worker to guide you about the nearest Government CVC where COVID vaccination will be available and the days of the week when this will be available. You need to carry your mobile phone and a photo identification document to get yourself vaccinated. The workers in the Government CVC will help you to register on the spot, get appointment and get vaccinated on the same day.

    Was this helpful?

  • Can a person get the COVID-19 vaccine without registration with Health Department?

    No, the registration of beneficiary is mandatory for vaccination for COVID-19 vaccine. Once registered, notification and information about the vaccine session date and time will be shared with the beneficiary. There will be a provision for walk-in to vaccination centres but they too would need to register on site before vaccination.

    Was this helpful?

  • What documents are required for registration of eligible beneficiary?

    Any of the below mentioned ID with Photo may be produced at the time of registration:
    Aadhaar Card

    • Driving License
    • Health Insurance Smart Card issued under the scheme of Ministry of Labour
    • Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) Job Card
    • Official identity cards issued to MPs/MLAs/MLCs
    • PAN Card
    • Passbooks issued by Bank/Post Office
    • Passport
    • Pension Document
    • Service Identity Card issued to employees by Central/ State Govt./ Public Limited Companies
    • Voter ID
    • People with comorbidities will have to carry the certificate of comorbidities, in the format shared here by a registered medical practitioner.

    Was this helpful?

  • Will a Photo ID be required at the time of registration?

    The Photo ID produced at the time of registration must be produced and verified at the time of vaccination.

    Was this helpful?

  • If a person is not able to produce Photo ID at the session site, whether s/he be vaccinated or not?

    Photo ID is a must for both registration and verification of beneficiary at session site to ensure that the intended person is vaccinated.

    Was this helpful?

  • How will the beneficiary receive information about due date of vaccination?

    Following online registration, beneficiary will receive SMS on their registered mobile number about the due date, place and time of vaccination.

    Was this helpful?

  • Will vaccinated beneficiaries receive information on the status of their vaccination after completion?

    Yes. On getting due dose of COVID-19 vaccine, the beneficiary will receive SMS on their registered mobile number. After all doses of vaccine are administered, a QR code based certificate will also be sent to the registered mobile number of the beneficiary.

    Was this helpful?

  • Which COVID-19 vaccines are licensed in India?

    Two vaccines that have been granted emergency use authorization by the Central Drugs Standard Control Organization (CDSCO) in India are Covishield® (AstraZeneca's vaccine manufactured by Serum Institute of India) and Covaxin® (manufactured by Bharat Biotech Limited).

    Was this helpful?

  • What is Emergency Use Authorization (EUA)/ Permission for restricted use?

    Emergency Use Authorization (EUA) is a regulatory mechanism to allow the use of vaccines and medicines to prevent and/or reduce the impact of life-threatening diseases or conditions as caused by COVID-19. However, before grant of the EUA, rigorous assessments of laboratory and clinical trial data, including data on quality, safety, production of protective antibodies and efficacy is conducted. Safety is particularly critical aspect of this scrutiny and a risk-versus- benefit evaluation is done in the context of a public health emergency. Full licensure is obtained when the manufacturer submits the complete data. EUA by Indian regulators is aligned with global guidelines.

    Was this helpful?

  • Is the EUA a new process introduced for COVID-19 Vaccine?

    Concept of EUA always existed to save the lives of people all over the world with vaccine and medicines for life threatening diseases while companies continue to obtain additional safety and effectiveness information to enable full licensure. Previously, EUAs have been granted to vaccines for outbreaks due to Anthrax, Ebola, Enterovirus, H7N9 Influenza, and Middle East Respiratory Syndrome. As of January 2021, nine COVID-19 vaccines were in emergency use in numerous countries around the globe.

    Was this helpful?

  • Have the vaccines undergone the needed clinical trials before EUA?

    Both the Indian COVID-19 vaccines have completed their Phase I & II trials. Covishield® has completed its Phase III trials in UK and the bridging trial in India.

    Was this helpful?

  • What is Phase I, II and III of clinical trial for a vaccine?

    Vaccine trial phases includes:-

    • Pre-clinical: Vaccine development in laboratory animals
    • Phase 1 Clinical trial (small number of participants): Assess vaccine safety, immune response and determine right dosage (short duration)
    • Phase 2 Clinical trial (few hundred participants): Assess safety and the ability of the vaccine to generate an immune response (short duration)
    • Phase 3 Clinical trial (thousands of participants): Determine vaccine effectiveness against the disease and safety in a larger group of people (duration 1-2 years)

    Was this helpful?

  • Why vaccination is not provided to children who are usual target?

    COVID-19 affects all age groups; however, morbidity & mortality is several times higher in adults particularly in those above the age of 50 years. Children have either asymptomatic or mild infection. The general practice is to first evaluate any new vaccine in older population and then age reduction is done to assess the safety and effectiveness in paediatric population. The currently available vaccines have not been evaluated in children so far. There are some clinical trials now underway to test the effectiveness and safety of the COVID-19 vaccines in children.

    Was this helpful?

  • What technology has been used in the development of the currently available two vaccines in India?

    Covishield® vaccine, manufactured by the Serum Institute of India, is a Viral Vector-based Technology which is also used to manufacture Ebola vaccine.

    Covaxin® vaccine, manufactured by the Bharat Biotech, is a Whole-virion Inactivated Coronavirus Vaccine which is also used to manufacture vaccines like Influenza, Rabies and Hepatitis- A.

    Was this helpful?

  • Will the COVID-19 vaccine be given to everyone simultaneously?

    Based on the potential availability of vaccines the Government of India has selected the priority groups who will be vaccinated on priority as they are at higher risk. The first group includes healthcare and frontline workers. The second group to receive COVID-19 vaccine will be persons over 60 years of age and persons between 45 and 59 years of age with comorbid conditions.

    Was this helpful?

  • Can a person presently having COVID-19 (confirmed or suspected) infection be vaccinated?

    Person with confirmed or suspected COVID-19 infection may increase the risk of spreading the same to others at vaccination site. For this reason, infected individuals should defer vaccination for 14 days after symptoms resolution.

    Was this helpful?

  • Is it necessary for a COVID-19 recovered person to take the vaccine? And if I had a COVID-19 infection and was treated, why should I receive the vaccine?

    Yes, it is advisable to receive a complete schedule of the COVID-19 vaccine irrespective of past history of infection with COVID-19. This will help in developing a strong immune response against the disease. Development of immunity or duration of protection after COVID-19 exposure is not established therefore it is recommended to receive the vaccine even after COVID-19 infection. Wait for 4-8 weeks after recovery from COVID symptoms before getting the vaccine.

    Was this helpful?

  • How will I know if I am eligible for vaccination?

    In the initial phase, the COVID-19 vaccine will be provided to the priority group - Health Care and Front-line workers. The second phase of vaccinations, starting March 1, 2021 will allow for all Indians above the age of 60 and Indians between the age of 45 and 59 with comorbidities to be vaccinationated. Registrations will be allowed on the Co-WIN 2.0 Portal, Aarogya Setu app etc. The comorbidities that make a person eligible for vaccinations are listed below:

    • Heart Failure with hospital admission in past one year
    • Post Cardiac Transplant/Left Ventricular Assist Device (LVAD)
    • Significant Left ventricular systolic dysfunction (LVEF <40%)
    • Moderate or Severe Valvular Heart Disease
    • Congenital heart disease with severe PAH or Idiopathic PAH
    • Coronary Artery Disease with past CABG/PTCA/MI AND Hypertension/Diabetes on treatment
    • Angina AND Hypertension/Diabetes on treatment
    • CT/MRI documented stroke AND Hypertension/Diabetes on treatment
    • Pulmonary Artery Hypertension AND Hypertension/Diabetes on treatment
    • Diabetes (> 10 years OR with complications) AND Hypertension on treatment
    • Kidney/ Liver/ Hematopoietic stem cell transplant: Recipient/On wait-list
    • End-Stage Kidney Disease on hemodialysis/ CAPD
    • Current prolonged use of oral corticosteroids/ immunosuppressant medications
    • Decompensated cirrhosis
    • Severe respiratory disease with hospitalizations in last two years/FEV1 <50%
    • Lymphoma/ Leukaemia/ Myeloma
    • Diagnosis of any solid cancer on or after 1st July 2020 OR currently on any cancer therapy
    • Sickle Cell Disease/ Bone marrow failure/ Aplastic Anemia/ Thalassemia Major
    • Primary Immunodeficiency Diseases/ HIV infection
    • Persons with disabilities due to Intellectual disabilities/ Muscular Dystrophy/ Acid attack with involvement of respiratory system/ Persons with disabilities having high support needs/ Multiple disabilities including deaf-blindness

    Was this helpful?

  • The Health Ministry has advised caution in vaccinating persons with a history of bleeding or coagulation disorder. How does a person know if he/she has a coagulation disorder? What tests can be conducted?

    There are a few bleeding disorders like 'haemophilia'. These persons should take the vaccine under the supervision of their treating physician. Patients who are admitted in hospital or ICU and have bleeding problems should delay the vaccination till they are discharged. However, several people with heart and brain disorders are on blood thinners like aspirin and antiplatelet drugs. They can continue with their medicines and have the vaccines. For them, vaccines are absolutely safe.

    Was this helpful?

  • The health advisory also states that those with immunity issues should be cautious about taking the vaccine. What are the markers of 'Immunity issues'?

    Immune issues are of two types: one, immunosuppression due to any disease such as AIDS, and people on immunosuppressant drugs such as anti-cancer drugs, steroids, etc. Second, immunodeficiency in people who suffers from some defect in the body's protective system such as congenital immunodeficiency.

    Currently, available COVID-19 vaccines do not have any live virus and therefore individuals with immune issues can have the vaccine safely. But the vaccine may not be as effective in them. One should inform the vaccinator about the medicines they consume and if they are suffering from any known immune issues. The vaccinator should have a record of one’s medical condition.

    Was this helpful?

  • Out of the multiple vaccines available, how is one or more vaccine chosen for administration?

    The safety and efficacy data from clinical trials of vaccine candidates are examined by Drug regulator of our country before granting the license for the same. Hence, all the COVID-19 vaccines that receive license will have comparable safety and efficacy. However, it must be ensured that the entire schedule of vaccination is completed by only one type of vaccine as different COVID-19 vaccines are not interchangeable.

    Was this helpful?

  • Does India have the capacity to store the COVID-19 vaccine at temperature of +2 to +8 degree Celsius and transport them at required temperature?

    India runs one of the largest Immunization programme in the world, catering to the vaccination needs of more than 26 million newborns and 29 million pregnant women. The programme mechanisms are being strengthened/geared up to effectively cater to the country’s large and diverse population.

    Was this helpful?

  • Are there any preventive measures and precautions that one needs to follow at the session site?

    We request you to rest at the vaccination centre for atleast half an hour after taking the COVID-19 vaccine. Inform the nearest health authorities/ANM/ASHA in case you feel any discomfort or uneasiness subsequently. Remember to continue following key COVID-19 Appropriate Behaviours like wearing of mask, maintaining hand sanitization and physical distance (or 6 feet or Do Gaj).

    Was this helpful?

  • What does trial mode mean for a vaccine recipient?

    The way we do in a clinical trial phase: first, the recipient will be asked to give a written consent. Additionally, the recipient will be followed up actively to see if the vaccine has led to any side effects. In short, it will be an extension of the Phase 3 trial. But in this, the person would know that he or she has received the vaccine, and not the placebo. It is completely voluntary.

    Was this helpful?

  • What is the safety and efficacy of the vaccines used in the country?

    To ensure that a vaccine is safe, we need to try it on a large number of people. The vaccine developers have not reduced the sample size at any stage of clinical trials rather it was bigger than what we usually test a vaccine on.

    When a vaccine is tested, most of the adverse events or unwanted effects, if any, occur in the first four to six weeks of its administration. So, in order to ensure that it is safe, we keep a close watch, for the first two-three months, on the people it has been given to. This data help us decide if a vaccine is safe. All concerned in the line of vaccine development, testing and evaluation have followed these procedures to the T. Both Indian vaccines are considered safe on this yardstick.

    As for the efficacy of the vaccine, we need time to tell how effective a vaccine is. All the global agencies have set the benchmark that only those vaccine candidates which show an efficacy of at least 50-60% will be considered. Most of the vaccines have shown an efficacy of 70-90% within the short period of two to three months of observation. Besides when a vaccine is given an emergency use authorizations/permission for restricted use, as in the case of the COVID-19 vaccine, the trial follow-up continues for one-two years to assess the total duration of protection the vaccine will provide.

    Was this helpful?

  • Which vaccine is better between Covisheild and Covaxin?

    There is no head-to-head comparison done between the two vaccines being used in India so one cannot choose one over the other. Both would work fine in preventing the infection as well as prevent a person from going into severe state of the disease. As a long-term effect, it would be preventing death for elderly people or those who have comorbidities.

    Was this helpful?

  • What medications should be avoided before taking COVID-19 vaccine and for how long?

    Currently, there is no such instruction. One can take one’s regular medication uninterruptedly. Just inform the vaccinator about the medicines you consume.

    Was this helpful?

  • Is the vaccine contraindicated in person with chronic diseases?

    Chronic diseases and morbidities like the cardiac, neurological, pulmonary, metabolic, renal and malignancies etc. are not contraindicated. In fact, the benefit of COVID-19 vaccines to reduce the risk of severe COVID-19 disease and death is for those who have these comorbidities.

    Was this helpful?

  • If one is taking medicines for illnesses like Cancer, Diabetes, Hypertension etc, can s/he take the COVID-19 vaccine and/or If I suffer from HTN/DM/CKD/heart disease/lipid disorders etc., can I safely take this vaccine?

    Yes, persons with one or more of these comorbid conditions are considered among the high risk category. They need to get COVID-19 vaccination. Overall, the vaccine is safe and efficacious in adults with comorbidity. The maximum benefit of getting the COVID-19 vaccine is for those who have such co-morbidities. However, if you are concerned for any specific reason, please consult your doctor.

    Was this helpful?

  • Do I need to use the mask/other COVID-19 appropriate precautions after receiving the vaccine?

    Yes, it is absolutely necessary that everyone who has received the COVID-19 vaccine should continue to follow the COVID-19 appropriate behaviour i.e., mask, do gaj ki doori and hand sanitization to protect themselves and those around from spreading the infection.

    Was this helpful?

  • How long I will remain protected after vaccination?

    Longevity of the immune response in vaccinated individuals is yet to be determined. Hence, continuing the use of masks, handwashing, physical distancing and other COVID-19 appropriate behaviours is strongly recommended.

    Was this helpful?

  • Does vaccination protect me against newer strains / mutated virus of SARS-CoV 2?

    The body responds to vaccination by making more than one type of antibodies to virus parts including spike protein. Therefore, all vaccines are expected to provide reasonable amount of protection against the mutated virus also. Based on the available data the mutations as reported are unlikely to make the vaccine ineffective.

    Was this helpful?

  • In how many days will the vaccination create an adequate immune response and protection?

    Adequate immune response takes 2-3 weeks after completion of entire vaccination schedule i.e., after the second dose of COVISHIELD® and COVAXIN®.

    Was this helpful?

  • Should you avoid alcohol after receiving the COVID-19 vaccine?

    As per experts, there is no evidence of alcohol impairing the effectiveness of the vaccine.

    Was this helpful?

  • What precautions I need to take after receiving the vaccine?

    Both the vaccines are safe but in case of any discomfort or complaint, ask the beneficiary to visit the nearest health facility and/or call the health worker whose phone number is given in the Co-WIN SMS received after vaccination.

    Was this helpful?

  • What is Ayush-64?

    Ayush-64 is an Ayurvedic formulation, developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), the apex body for research in Ayurveda under the Ministry of Ayush. Originally developed in 1980 for the management of Malaria, this drug has now been repurposed for Covid 19 as its ingredients showed notable antiviral, immune-modulator and antipyretic properties. The in-silico study done on Ayush 64 showed that 35 out of 36 of its Phyto-constituents have high binding affinity against COVID 19 virus. The formulation has also shown very promising results in Influenza like illnesses. With scientific evidence generated from 06 clinical studies across India, Ayush 64 has been identified as a potential adjunct to standard care in the management of asymptomatic, mild and moderate COVID 19 to improve the clinical recovery and quality of life.

    Was this helpful?

  • Who can take Ayush-64?

    It can be taken by patients at any stage of the COVID-19 disease. However, its efficacy was scientifically studied in asymptomatic, mild and moderate disease without risk factors for poor outcome and those not requiring emergency interventions or hospitalization are eligible to take Ayush-64. Patients of mild to moderate COVID-19 cases showing initial symptoms like fever, malaise, body ache, nasal congestion, nasal discharge, headache, cough etc. and of asymptomatic cases of COVID-19 can start taking Ayush 64 within 7 days of diagnosis of the disease through RT-PCR for better outcome.

    Was this helpful?

  • Why should I take Ayush-64?

    Ayush-64 is found to significantly enhance the speed of clinical recovery in terms of disease symptoms and severity. It also has significant beneficial effects on general health, fatigue, anxiety, stress, appetite, general wellbeing and sleep.

    Was this helpful?

  • Is its efficacy on COVID 19 scientifically proven?

    Ayush-64 is a poly herbal formulation developed in compliance to all regulatory requirements as well as quality and pharmacopoeial standards by the Central Council for Research in Ayurvedic Sciences (CCRAS) the apex body for research in Ayurveda under the Ministry of Ayush. It has been scientifically established to be useful in the treatment of asymptomatic, mild and moderate COVID-19 infection as an adjunct to standard care through robust clinical trials conducted in the country. The results of the clinical trials demonstrated that Ayush 64 as an adjunct to standard of care (SoC) showed clinically significant improvement and thus lesser period of hospitalization as compared to SoC alone.

    Was this helpful?

  • What is the ideal dose for Ayush-64 in COVID 19 patients?

    The dose for asymptomatic COVID 19 case is 2 tablets of 500 mg twice daily one hour after meals with warm water for 14 days. The dose for mild to moderate cases is 2 tablets of 500 mg thrice daily one hour after meals with warm water for 14 days.

    Was this helpful?

  • Are there any side effects of Ayush-64?

    Loose motions can occur in some patients, which is self-limiting and does not require any medical intervention.

    Was this helpful?

  • Can Ayush-64 be taken as prophylactic medicine also?

    It may be used for prophylaxis also, in a dose of 2 tablets of 500 mg twice daily, but its efficacy as a prophylactic agent has not been demonstrated through clinical studies. But if a person is exposed to a COVID-19 case, Ayush-64 can be taken when symptoms appear. In such instances, the person should get tested for COVID-19 through RT-PCR or Rapid antigen test and should follow SoC.

    Was this helpful?

  • Should Ayush-64 be taken as standalone treatment in mild cases?

    It can be taken as a standalone treatment in mild cases under the supervision of an Ayurvedic physician, provided there is availability of appropriate referral facilities. However, it is advised that Ayush64 should be taken as adjunct to the SoC in mild to moderate disease, when the patient is under home isolation. Ayush-64, shall only be used as per the advice of a qualified Ayush practitioner.

    Was this helpful?

  • For how many days should Ayush-64 be taken?

    Ayush-64 can be taken for a minimum period of 14 days. However, if required, it can be taken up to 12 weeks, as per the advice of a qualified Ayush practitioner. It has been scientifically proven to be safe up to 12 weeks, through clinical studies.

    Was this helpful?

  • How should Ayush-64 be taken?

    It can be taken with warm water, preferably one hour after food.

    Was this helpful?

  • Can a COVID-19 patient with other comorbidities take Ayush-64?

    Patients with co-morbidities like hypertension, diabetes etc., can take Ayush-64 for asymptomatic, mild to moderate disease and are advised not to discontinue their respective medications.

    Was this helpful?

  • Is Ayush-64 safe, if taken after vaccination?

    Yes. If a person gets infected even after vaccination, Ayush-64 can be taken within 7 days of testing RT-PCR positive for SARS CoV-2, in consultation with an Ayush Physician. However, evidence in favor of it has not been elicited through scientific studies.

    Was this helpful?

  • Is it safe in pregnant and lactating women?

    The safety of Ayush-64 in cases pregnant and lactating women is not established through scientific studies.

     

    Was this helpful?

  • Is Ayush-64 available in the market?

    It is available in market and can be purchased from Ayurvedic pharmacies. However, it should be ensured that, it should not be used as an over the counter prescription (OTC) and shall only be used under the supervision of Ayurvedic physicians.

    Was this helpful?

  • What guidelines should I follow while taking Ayush-64?

    There are no special precautions to be followed while using Ayush-64. However, one must follow all the COVID-19 related guidelines given by Ministry of Ayush and Ministry of Health and Family Welfare, Government of India.

    Was this helpful?

  • What is Omicron and what makes it a variant of concern (VoC)?

    It is a new variant of SARS-CoV-2 that has recently been reported from South Africa on 24th November 2021 called as B.1.1.529 or Omicron (based on Greek alphabets like alpha, beta, delta etc). This variant has shown a very large number of mutations, especially more than 30 on the viral spike protein, which is the key target of the immune response.


    Given the collection of mutations in Omicron, which earlier individually have been associated with increased infectivity and/or immune evasion, and the sudden rise in number of positive cases in South Africa, World Health Organization has declared Omicron as a Variant of Concern (VoC).

    Was this helpful?

  • Can the currently used diagnostics methods, detect Omicron?

    The most accepted and commonly used method of diagnostic for SARS-CoV2 Variant is RT-PCR method. This method detects specific genes in the virus, such as Spike (S), Enveloped (E) and Nucleocapsid (N) etc to confirm the presence of virus. However, in case of Omicron, as the S gene is heavily mutated, some of the primers may lead to results indicating absence of the S gene (called as S gene drop out). This particular S gene drop out along with the detection of other viral genes could be used a diagnostic feature of Omicron. However, for final confirmation of the omicron variant genomic sequencing is required. 

    Was this helpful?

  • How concerned should we be about the new VoC?

    WHO declares a variant as a VoC after assessment when there is increase in transmissibility or detrimental change in COVID-19 epidemiology; OR increase in virulence or change in clinical disease presentation; OR decrease in effectiveness of public health and social measures or available diagnostics, vaccines, therapeutics. (Source: WHO)

    It is important to highlight that Omicron has been declared VoC based on the observed mutations, their predicted features of increased transmission and immune evasion, and preliminary evidence of detrimental change in COVID-19 epidemiology, such as increased reinfections. The definitive evidence for increased remission and immune evasion is awaited.

    Was this helpful?

  • What precautions should we take?

    The precautions and steps to be taken remain same as before. It is essential to mask yourself properly, take both doses of vaccines (if not yet vaccinated), maintain social distancing and maintain good ventilation to the maximum possible. 

    Was this helpful?

  • Will there be a third wave?

    Omicron cases are increasingly being reported from countries outside of South Africa and given its characteristics, it is likely to spread to more countries including India. However, the scale and magnitude of rise in cases and most importantly the severity of disease that will be caused is still not clear. Further, given the fast pace of vaccination in India and high exposure to delta variant as evidenced by high seropositivity, the severity of the disease is anticipated to be low. However, scientific evidence is still evolving.

    Was this helpful?

  • Will the existing vaccines work against Omicron?

    While, there is no evidence to suggest that existing vaccines do not work on Omicron, some of the mutations reported on Spike gene may decrease the efficacy of existing vaccines. However, vaccine protection is also by antibodies as well as by cellular immunity, which is expected to be relatively better preserved. Hence vaccines are expected to still offer protection against severe
    disease and, vaccination with the available vaccines is crucial. If eligible, but not vaccinated, one should get vaccinated. 

    Was this helpful?

  • How is India responding?

    Indian government is monitoring the situation closely and is issuing suitable guidelines from time to time. Meanwhile, the scientific and medical community is geared up for developing and deploying diagnostics, carrying out genomic surveillance, generating evidence about viral and epidemiologic characteristics, and development of therapeutics. 

    Was this helpful?

  • Why do variants occur?

    Variants are normal part of evolution and as long as the virus is able to infect, replicate and transmit, they will continue to evolve. Further, not all variants are dangerous and most often than not, we don’t notice them. Only when they are more infectious, or can reinfect people etc they gain prominence. The most important step to avoid generation of variants is to reduce the number of
    infections.

    Was this helpful?

Video Gallery

200

  • India Fights Corona: Prof. K. VijayRaghavan, PSA to the Govt of India
  • India Fights Corona: Prof. K. VijayRaghavan, PSA to the Govt of India
  • India Fights Corona: Prof. K. VijayRaghavan, PSA to the Govt of India
  • India Fights Corona: Prof. K. VijayRaghavan, PSA to the Govt of India
  • India Fights Corona: Prof. K. VijayRaghavan, PSA to the Govt of India
  • India Fights Corona: Prof. K. VijayRaghavan, PSA to the Govt of India
  • India Fights Corona: Prof. K. VijayRaghavan, PSA to the Govt of India
  • India Fights Corona: Prof. K. VijayRaghavan, PSA to the Govt of India
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • Ms. Sumita Dawra (Joint Secretary, Government of India)
  • Ms. Sumita Dawra (Joint Secretary, Government of India)
  • Ms. Sumita Dawra (Joint Secretary, Government of India)
  • Ms. Sumita Dawra (Joint Secretary, Government of India)
  • Ms. Sumita Dawra (Joint Secretary, Government of India)
  • Ms. Sumita Dawra (Joint Secretary, Government of India)
  • Ms. Sumita Dawra (Joint Secretary, Government of India)
  • Ms. Sumita Dawra (Joint Secretary, Government of India)
  • Mr. Apoorva Oza (CEO, Aga Khan Rural Support Program, India)
  • Mr. Apoorva Oza (CEO, Aga Khan Rural Support Program, India)
  • Mr. Apoorva Oza (CEO, Aga Khan Rural Support Program, India)
  • Mr. Apoorva Oza (CEO, Aga Khan Rural Support Program, India)
  • Mr. Apoorva Oza (CEO, Aga Khan Rural Support Program, India)
  • Mr. Apoorva Oza (CEO, Aga Khan Rural Support Program, India)
  • Mr. Apoorva Oza (CEO, Aga Khan Rural Support Program, India)
  • Mr. Apoorva Oza (CEO, Aga Khan Rural Support Program, India)
  • Mr. Mohammad Mustafa (Chairman and MD, SIDBI)
  • Mr. Mohammad Mustafa (Chairman and MD, SIDBI)
  • Mr. Mohammad Mustafa (Chairman and MD, SIDBI)
  • Mr. Mohammad Mustafa (Chairman and MD, SIDBI)
  • Mr. Mohammad Mustafa (Chairman and MD, SIDBI)
  • Mr. Mohammad Mustafa (Chairman and MD, SIDBI)
  • Mr. Mohammad Mustafa (Chairman and MD, SIDBI)
  • Mr. Mohammad Mustafa (Chairman and MD, SIDBI)
  • Dr. Ajay Kumar, Defence Secretary, Government of India
  • Dr. Ajay Kumar, Defence Secretary, Government of India
  • Dr. Ajay Kumar, Defence Secretary, Government of India
  • Dr. Ajay Kumar, Defence Secretary, Government of India
  • Dr. Ajay Kumar, Defence Secretary, Government of India
  • Dr. Ajay Kumar, Defence Secretary, Government of India
  • Dr. Ajay Kumar, Defence Secretary, Government of India
  • Dr. Ajay Kumar, Defence Secretary, Government of India
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • India Fights Corona
  • Mr. Sanjv Mehta, Chairman and MD, Hindustan Unilever Limited
  • Mr. Sanjv Mehta, Chairman and MD, Hindustan Unilever Limited
  • Mr. Sanjv Mehta, Chairman and MD, Hindustan Unilever Limited
  • Mr. Sanjv Mehta, Chairman and MD, Hindustan Unilever Limited
  • Mr. Sanjv Mehta, Chairman and MD, Hindustan Unilever Limited
  • Mr. Sanjv Mehta, Chairman and MD, Hindustan Unilever Limited
  • Mr. Sanjv Mehta, Chairman and MD, Hindustan Unilever Limited
  • Mr. Sanjv Mehta, Chairman and MD, Hindustan Unilever Limited
  • Ms. Anisha Singh, Founding Partner, SheCapital
  • Ms. Anisha Singh, Founding Partner, SheCapital
  • Ms. Anisha Singh, Founding Partner, SheCapital
  • Ms. Anisha Singh, Founding Partner, SheCapital
  • Ms. Anisha Singh, Founding Partner, SheCapital
  • Ms. Anisha Singh, Founding Partner, SheCapital
  • Ms. Anisha Singh, Founding Partner, SheCapital
  • Ms. Anisha Singh, Founding Partner, SheCapital
  • Ms. Sairee Chahal, Founder & CEO, Sheroes
  • Ms. Sairee Chahal, Founder & CEO, Sheroes
  • Ms. Sairee Chahal, Founder & CEO, Sheroes
  • Ms. Sairee Chahal, Founder & CEO, Sheroes
  • Ms. Sairee Chahal, Founder & CEO, Sheroes
  • Ms. Sairee Chahal, Founder & CEO, Sheroes
  • Ms. Sairee Chahal, Founder & CEO, Sheroes
  • Ms. Sairee Chahal, Founder & CEO, Sheroes
  • Apr 11, 2020 Ms. Astha Ahluwalia (Chief Psychologist & Partner, Reboot Wellness)
  • Apr 11, 2020 Ms. Astha Ahluwalia (Chief Psychologist & Partner, Reboot Wellness)
  • Apr 11, 2020